Showing 771-780 of 10531 results for "".
Technology: The Threat and the Opportunity
https://practicaldermatology.com/issues/june-2024/technology-the-threat-and-the-opportunity/26538/Joel Schlessinger, MD, chief cosmetic surgery editor of Practical Dermatology, talks about the perils and promise brough about by shifts in technology, both in his own practice and in the wider field of dermatology.Meet the Moys: Father and Daughter Dermatologists Reflect on the Specialty
https://practicaldermatology.com/topics/feature/moy-father-daughter-reflect-on-dermatology-specialty/26578/Meet the Moys: Father and Daughter Dermatologists Reflect on the SpecialtyOn Dosage and Diet: Isotretinoin 101
https://practicaldermatology.com/topics/general-topics/on-dosage-and-diet-isotretinoin-101/21445/Isotretinoin is one of the most essential agents in the treatment of acne, but dietary and dosage considerations must be made to maximize efficacy. Author:Joshua Zeichner, MDThe Case for JAK Inhibitors to Treat AD
https://practicaldermatology.com/topics/atopic-dermatitis/case-jak-inhibitors-treat-ad/27109/E. James Song, MD, FAAD, Director of Clinical Research and Co-Chief Medical Officer for Frontier Dermatology, discusses his presentation “JAK Inhibitors in Atopic Dermatitis” from the 2024 American Academy of Dermatology (AAD) Innovation Academy.DermWireTV: Candela + Merz Aesthetics Partnership, COVID-19 Vaccines & Fillers, Almirall's Klisyri, MetSyn & PsO
https://practicaldermatology.com/topics/skin-cancer-photoprotection/dermwiretv-candela-merz-aesthetics-partnership-covid-19-vaccines-and-fillers-almiralls-klisyri-metsyn-and-pso/19893/Klisyri® (tirbanibulin) ointment 1% from Almirall will be available for treatment of AKs by the end of this quarter; Ayman Grada, MD discusses. Are patients who have received dermal filler injections at risk for developing reactions to the COVID-19 vaccine? Joel L. Cohen, MD and Doris Day, MD weighRobert Grant Steps Down at Alphaeon; Skin Cancer Special Edition
https://practicaldermatology.com/topics/skin-cancer-photoprotection/dermwiretv-robert-grant-steps-down-at-alphaeon-skin-cancer-special-edition/18595/Robert Grant is no longer CEO of lifestyle healthcare company Alphaeon. Mr. Grant founded Alphaeon in 2013 as a wholly owned subsidiary of Strathspey Crown LLC, a private equity firm located in Newport Beach, CA, where he serves as Chairman. Also in this issue, a closer look at skin cancer. May is SCosmetic Boot Camp 2018 Presenter Insight
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/cosmetic-boot-camp-2018-presenter-insight/18290/Get up to date on Cosmetic Bootcamp. Presenters provide updates on microneedling, radiofrequency devices, lasers, fillers, neurotoxins, and more. The Cosmetic Bootcamp® provides training and educational opportunities for aesthetic medicine physicians and their staff. Hear from: Mary Lupo, MD; Vic NaAcne & Rosacea: 2020 and Beyond
https://practicaldermatology.com/topics/acne-rosacea/acne-rosacea-2020-and-beyond/19734/Guy Webster, MD, PhD reviews developments in acne and rosacea.Radiesse in Practice
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/radiesse-in-practice/19202/Heidi Waldorf, MD, discusses Radiesse and its use in her practice.Educational Excellence
https://practicaldermatology.com/series/dermatology-education-foundation/educational-excellence/19994/The excellent faculty and top-notch education are the highlights of Dermatology Education Foundation conferences, says Kara S. Gooding, MMS, PA-C.